VIVEbiotech has become a partner of Alliance for Regenerative Medicine

Alliance for Regenerative Medicine (ARM) is the preeminent global advocate for regenerative and advanced therapies. ARM fosters research, development, investment and commercialization of transformational treatments and cures for patients worldwide.

ARM’s membership is diverse, representing leading regenerative medicine companies and investors, university-based and non-profit research institutions, patient advocacy groups, pharmaceutical companies engaged in regenerative medicine research, and other organizations supporting regenerative medicine.

Based on this  facts, becoming part of this association is very important for VIVEbiotech as a leader CDMO manufacturing Lentiviral vectors both for European and USA markets.

Additionally, VIVEbiotech is already activly involved in the following  ARM comittees:

– EU Regulatory Committee

– Science and Technology comittee

Do not hesitate to find more information about it in: